CHD
40
3
NTAP
55
-3
CCI
36
3
MRK
58
2
ADI
70
-6
GOOG
67
-2
GME
75
4
AAL
51
-6
IR
65
-4
HCA
62
2
PH
60
-15
MCHP
47
2
WEC
43
-27
RCL
62
-18
AES
49
-2
YUM
56
-16
MLM
61
-5
XRX
41
-18
SE
41
-38
WM
57
-22
CHD
40
3
NTAP
55
-3
CCI
36
3
MRK
58
2
ADI
70
-6
GOOG
67
-2
GME
75
4
AAL
51
-6
IR
65
-4
HCA
62
2
PH
60
-15
MCHP
47
2
WEC
43
-27
RCL
62
-18
AES
49
-2
YUM
56
-16
MLM
61
-5
XRX
41
-18
SE
41
-38
WM
57
-22
Financhill
Back

Nuveen Pennsylvania Quality Municipal Income Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
25

NQP
Nuveen Pennsylvania Quality Municipal Income Fund

Last Price:
$12.02
Seasonality Move:
1.8%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.34
Seasonality Move:
14.46%
Sell
25
Nuveen Pennsylvania Quality Municipal Income Fund (NQP) is a Sell

Is Nuveen Pennsylvania Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen Pennsylvania Quality Municipal Income Fund [NQP] share price is $12.03. The Score for NQP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NQP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NQP Stock Price Chart

What is Nuveen Pennsylvania Quality Municipal Income Fund's stock price today?

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $54.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

NQP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 43.89 Sell
Chaikin Money Flow: 104200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.07 - 12.17) Sell
Bollinger Bands (100): (11.15 - 12.19) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 45.45 Sell
Chaikin Money Flow: -1078798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.55 - 56.85) Buy
Bollinger Bands (100): (52.52 - 65.44) Sell

NQP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 12.11 Sell
50-day SMA: 12.09 Sell
200-day SMA: 11.41 Buy
8-day EMA: 12.07 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12 Buy
200-day EMA: 11.63 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.72 Sell
20-day SMA: 54.52 Buy
50-day SMA: 59.78 Sell
200-day SMA: 50.98 Buy
8-day EMA: 56.04 Sell
20-day EMA: 55.88 Sell
50-day EMA: 56.44 Sell
200-day EMA: 37.2 Buy

Nuveen Pennsylvania Quality Municipal Income Fund Earnings Growth & NQP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Nuveen Pennsylvania Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):